[1] TUR.KASPA R,SHAUL Y,MOORE DD,et al. The glucocorticoid receptor recognizes a specific nucleotide in hepatitis B virus DNA causing increased activity of the HBV enhancer[J]. Virology,1988,167（2）：630-633.
[2] ALMOG Y,KLEIN A,ADLER R,et al. Estrogen suppresses hepatitis B virus expression in male athymic mice transplanted with HBV transfected HepG-2 cells[J]. Antiviral Res,1992,19（4）：285-293.
[3] DENG G,ZHOU G,ZHAI Y,et al. Association of estrogen receptor alpha polymorphisms with susceptibility to chronic hepatitis B virus infection[J]. Hepatology,2004,40（2）：318-326.
[4] COHN CS,SULLIVAN JA,KIEFER Y,et al. Identification of an enhancer element in the estrogen receptor upstream region：implications for regulation of ER transcription in breast cancer[J]. Mol Cell Endocrinol,1999,158（1-2）：25-36.
[5] 谢建萍,龚先琼,谭德明,等. 雌激素受体基因多态性与乙型肝炎肝硬化的相关性研究[J]. 中南大学学报（医学版）,2006,31（3）：379-382.
[6] ZHAI Y,ZHOU G,DENG G,et al. Estrogen receptor alpha polymorphisms associated with susceptibility to hepatocellular carcinoma in hepatitis B virus carriers[J]. Gastroenterology,2006,130（7）：2001-2009.
[7] YAGER JD. Endogenous estrogens as carcinogens through metabolic activation[J]. J Natl Cancer Inst Monogr,2000,27：67-73.
[8] VAN DUIJNHOVN FJ,BEZEMER ID,PEETERS PH,et al. Polymorphisms in the estrogen receptor alpha gene and mammographic density[J]. Cancer Epidemiol Biomarkers Prev,2005,14（11Pt1）：2655-2660.
[9] GONZALEZ-MANCHR R,GALAN JJ,CRESPO C,et al. Analysis of the ERalpha germline PvuII marker in breast cancer risk[J]. Med Sci Monit,2008,14（3）：CR136-143.
[10] SOBCZUK A,PERTYNSKI T,SMOLARZ B,et al. The analysis of estrogen receptor alpha （ER-alpha） gene Pvull and Xbal polymorphisms in postmenopausal women with breast cancer[J]. Pol Merkur Lekarski,2008,25（145）：43-45.
[11] GONZALEZ-ZULOETA LADD AM,VASQUEZ AA,RIVADENEIRA F,et al. Estrogen receptor alpha polymorphisms and postmenopausal breast cancer risk[J]. Breast Cancer Res Treat,2008,107（3）：415-419.
[12] NAM HS,SHIN MH,KWEON SS,et al. Association of estrogen receptor-alpha gene polymorphisms with bone mineral density in postmenopausal Korean women[J]. J Bone Miner Metab,2005,23（1）：84-89.
[13] IVANOVA JT,DOUKOVA PB,BOYANOV MA,et al. PvuII and XbaI polymorphisms of the estrogen receptor gene and bone mineral density in a Bulgarian population sample[J].Hormones （Athens）,2007,6（1）：36-43.
[14] WANG CL,TANG XY,CHEN WQ,et al. Association of estrogen receptor alpha gene polymorphisms with bone mineral density in Chinese women：a meta-analysis[J]. Osteoporos Int,2007,18（3）：295-305.
[15] VALIMAKI VV,PIIPPO K,VALIMAKI S,et al. The relation of the XbaI and PvuII polymorphisms of the estrogen receptor gene and the CAG repeat polymorphism of the androgen receptor gene to peak bone mass and bone turnover rate among young healthy men[J]. Osteoporos Int,2005,16（12）：1633-1640.
[16] JIAN WX,YANG YJ,LONG JR,et al. Estrogen receptor alpha gene relationship with peak bone mass and body mass index in Chinese nuclear families[J]. J Hum Genet,50（9）：477-482.
[17] SHEARMAN AM,COOPER JA,KOTWINSKI PJ,et al. Estrogen receptor alpha gene variation and the risk of stroke[J]. Stroke,2005,36（10）：2281-2282.
[18] LAZAROS L,MARKOULA S,XITA N,et al. Association of estrogen receptor-alpha gene polymorphisms with stroke risk in patients with metabolic syndrome[J]. Acta Neurol Scand,2008,117（3）;186-190.
[19] MOLVAREC A,SZEPLAKI G,KOVACS M,et al. Estrogen receptor alpha（ESR1） PvuII and XbaI gene polymorphisms in ischemic stroke in a Hungarian population[J]. Clin Chim Acta,2007,382（1-2）：100-105.
[20] MOLVAREC A,VER A,FEKETE A,et al. Association between estrogen receptor alpha （ESR1） gene polymorphisms and severe preeclampsia[J]. Hypertens Res,2007,30（3）：205-211. |
